Beneficial effects of alternate dietary regimen on liver inflammation, atherosclerosis and renal activation

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Wielinga, Peter Y ^a,c   Yakala, Gopala K ^b,c   Heeringa, Peter ^b,c   Kleemann, Robert ^a,c   Kooistra, Teake ^a  

^a TNO   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1; CHOLESTEROL;

ALTERNATE DIETARY REGIMEN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CONTROLLED STUDY; DIET; DIET THERAPY; FEMALE; HEPATITIS; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; MACROPHAGE; MOUSE; NEPHRITIS; NONHUMAN; NUTRITIONAL ASSESSMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; THERAPY EFFECT; WESTERN DIET; ANIMAL; ATHEROSCLEROSIS; CALORIC RESTRICTION; INFLAMMATION; KIDNEY; LIVER; METABOLISM; METHODOLOGY;

MUS;

ANIMALS; ATHEROSCLEROSIS; CALORIC RESTRICTION; CHEMOKINE CCL2; CHOLESTEROL; FEMALE; INFLAMMATION; KIDNEY; LIVER; MICE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79953647391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018432     Document Type: Article

References (20)

1. Hu FB, Willett WC, (2002) Optimal Diets for Prevention of Coronary Heart Disease. JAMA 288: 2569-2578.
2. Turk MW, Yang K, Hravnak M, Sereika SM, Ewing LJ, et al. (2009) Randomized clinical trials of weight loss maintenance: a review. J Cardiovasc Nurs 24: 58-80.
3. Fontana L, (2008) Calorie restriction and cardiometabolic health. Eur J Cardiovasc Prev Rehabil 15: 3-9.
4. Varady KA, Bhutani S, Church EC, Klempel MC, (2009) Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 90: 1138-1143.
5. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, et al. (2007) Mouse Models for Atherosclerosis and Pharmaceutical Modifiers. Arterioscler Thromb Vasc Biol 27: 1706-1721.
6. Kleemann R, Verschuren L, van Erk MJ, Nikolsky Y, Cnubben NH, et al. (2007) Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 8: R200.
7. Rein D, Schijlen E, Kooistra T, Herbers K, Verschuren L, et al. (2006) Transgenic flavonoid tomato intake reduces C-reactive protein in human C-reactive protein transgenic mice more than wild-type tomato. J Nutr 136: 2331-2337.
8. Kleemann R, Verschuren L, van Erk MJ, Nikolsky Y, Cnubben NH, et al. (2007) Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 8: R200.
9. Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, et al. (2010) Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance. PLoS ONE 5: e8817.
10. Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, et al. (2010) Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance. PLoS ONE 5: e8817.
11. Kooistra T, Verschuren L, de Vries-van der Weij, Koenig W, Toet K, et al. (2006) Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol. Arterioscler Thromb Vasc Biol 26: 2322-2330.
12. Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, et al. (2005) Effect of Low Dose Atorvastatin Versus Diet-Induced Cholesterol Lowering on Atherosclerotic Lesion Progression and Inflammation in Apolipoprotein E*3-Leiden Transgenic Mice. Arterioscler Thromb Vasc Biol 25: 161-167.
13. Li Y, Schwabe RF, Vries-Seimon T, Yao PM, Gerbod-Giannone MC, et al. (2005) Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and MAP kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 280: 21763-21772.
14. Varady KA, Roohk DJ, Evoy-Hein BK, Gaylinn BD, Thorner MO, et al. (2008) Modified alternate-day fasting regimens reduce cell proliferation rates to a similar extent as daily calorie restriction in mice. FASEB J 22: 2090-2096.
15. Varady KA, Allister CA, Roohk DJ, Hellerstein MK, (2010) Improvements in body fat distribution and circulating adiponectin by alternate-day fasting versus calorie restriction. The Journal of Nutritional Biochemistry 21: 188-195.
16. Kleemann R, Verschuren L, van Erk MJ, Nikolsky Y, Cnubben NH, et al. (2007) Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 8: R200.
17. Wiggins JE, Patel SR, Shedden KA, Goyal M, Wharram BL, et al. (2010) NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol 21: 587-597.
18. Van Liew JB, Davis FB, Davis PJ, Noble B, Bernardis LL, (1992) Calorie restriction decreases microalbuminuria associated with aging in barrier-raised Fischer 344 rats. Am J Physiol 263: F554-F561.
19. Jiang T, Liebman SE, Lucia MS, Phillips CL, Levi M, (2005) Calorie Restriction Modulates Renal Expression of Sterol Regulatory Element Binding Proteins, Lipid Accumulation, and Age-Related Renal Disease. J Am Soc Nephrol 16: 2385-2394.
20. Hotamisligil GS, (2010) Endoplasmic reticulum stress and atherosclerosis. Nat Med 16: 396-399.